Last reviewed · How we verify
placebo air aerosol
Placebo air aerosol delivers inert air via aerosol inhalation as a control comparator with no active pharmacological mechanism.
Placebo air aerosol delivers inert air via aerosol inhalation as a control comparator with no active pharmacological mechanism. Used for Clinical trial control arm (non-therapeutic).
At a glance
| Generic name | placebo air aerosol |
|---|---|
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
This is a placebo formulation used in clinical trials as a control arm. It consists of aerosolized air with no active pharmaceutical ingredient and therefore produces no direct pharmacological effect. It serves to establish baseline efficacy and safety comparisons against active treatment arms in respiratory or inhalation studies.
Approved indications
- Clinical trial control arm (non-therapeutic)
Common side effects
Key clinical trials
- InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS (PHASE3)
- Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx) (PHASE4)
- ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial. (PHASE3)
- Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma (PHASE3)
- Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms. (PHASE2)
- IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase (PHASE2)
- Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma (PHASE2)
- Functional Magnetic Resonance Imaging (fMRI) Study of Nasal Strips in Nasal Congestion (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- placebo air aerosol CI brief — competitive landscape report
- placebo air aerosol updates RSS · CI watch RSS
- Centre Hospitalier Universitaire de Nice portfolio CI